Apollo Endosurgery Inc
NASDAQ:APEN
Apollo Endosurgery Inc
Cash from Operating Activities
Apollo Endosurgery Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Apollo Endosurgery Inc
NASDAQ:APEN
|
Cash from Operating Activities
-$31.3m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-14%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Operating Activities
$3.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Operating Activities
$2.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
40%
|
CAGR 10-Years
8%
|
|
Stryker Corp
NYSE:SYK
|
Cash from Operating Activities
$3.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Operating Activities
$7.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Operating Activities
$1.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
See Also
What is Apollo Endosurgery Inc's Cash from Operating Activities?
Cash from Operating Activities
-31.3m
USD
Based on the financial report for Dec 31, 2022, Apollo Endosurgery Inc's Cash from Operating Activities amounts to -31.3m USD.
What is Apollo Endosurgery Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-14%
Over the last year, the Cash from Operating Activities growth was -116%. The average annual Cash from Operating Activities growth rates for Apollo Endosurgery Inc have been -7% over the past three years , -19% over the past five years , and -14% over the past ten years .